Nasus Pharma Ltd. vs PolyPid Ltd.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- PolyPid Ltd. is the larger company by market value: $103 M against $45 M for Nasus Pharma Ltd., 2.3 times as much (market caps of Aug 1, 2026). Nasus Pharma Ltd.'s value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet. PolyPid Ltd.'s value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.
- Both made a net loss: $6 M for Nasus Pharma Ltd. and $34 M for PolyPid Ltd.
Market cap history
● Nasus Pharma Ltd.● PolyPid Ltd.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Not enough data yet.
Side by side
| Measure | Nasus Pharma Ltd. NSRX · #21,606 in the world | PolyPid Ltd. PYPD · #18,571 in the world |
|---|---|---|
| Profile | ||
| Country | 🇮🇱 Israel | 🇮🇱 Israel |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Founded | — | — |
| Size | ||
| Market cap | $45 M | $103 M |
| Revenue | $1.2 B | — |
| Net income | $-6 M▲ best | $-34 M |
| Employees | — | 59 |
| Valuation | ||
| Price to sales | 0.0× | — |
| Price to book | 16.3× | 9.4× |
| Free cash flow yield | -10.9%▲ best | -27.2% |
| Profitability | ||
| Operating margin | -0.4% | — |
| Net margin | -0.5% | — |
| Return on equity | — | -366.4% |
| Growth | ||
| Earnings per share growth | — | -57.4% |
| Cash | ||
| Free cash flow margin | -0.4% | — |
| Altman Z-score zone | — | — |
| Data as of | Market cap Aug 2026; ratios FY2025 | Market cap Aug 2026; ratios FY2025 |
Questions and answers#
Which is bigger, Nasus Pharma Ltd. or PolyPid Ltd.?
PolyPid Ltd. is the larger company by market value: $103 M against $45 M for Nasus Pharma Ltd., 2.3 times as much (market caps of Aug 1, 2026). Nasus Pharma Ltd.'s value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet. PolyPid Ltd.'s value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.
Which makes more money, Nasus Pharma Ltd. or PolyPid Ltd.?
Both made a net loss: $6 M for Nasus Pharma Ltd. and $34 M for PolyPid Ltd.